![]() |
|
|||
![]() |
|
|||
![]() |
![]() |
You
are here: |
|
ARCH
|
PROGRESS: PROGesterone after previous preterm birth for prevention of neonatal RESpiratory distress SyndromeThis trial is currently recruiting. The trial is open for other centres to join the study. Neonatal respiratory disease, due to immature lung development, is a significant consequence of preterm birth and the major cause of early neonatal mortality and morbidity. The incidence of preterm birth (birth less than 37 weeks gestation) is approximately 7.0%, with 2.6% of all births occurring before 34 weeks gestation. The exact mechanism of the onset of labour in humans is complex. Progesterone is essential for maintaining pregnancy, having an important role in uterine relaxation. Although recent reports of progesterone supplementation for women at risk of preterm birth show promise, there is currently insufficient data to recommend the use of progesterone to prevent preterm birth. This trial will involve women who have a history of spontaneous preterm birth at less than 34 weeks in the preceding pregnancy and will compare vaginal progesterone pessaries with placebo pessaries.
ReferencesDodd J, Ashwood P, Flenady V, Jenkins-Manning S, Cincotta R, Crowther CA. A Survey of clinicians and patients towards the use of progesterone for women at risk of preterm birth. Aust N Z J Obstet Gynaecol 2007;47:106-109. (IF 0.835) Dodd JM, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth. Cochrane Database of Systematic Reviews 2006, Issue 1. Dodd JM, Crowther CA, Cincotta R, Flenady V & Robinson JS. Progesterone supplementation for prevention of preterm birth: a systematic review and meta-analysis. Acta Obstetrica et Gynecologica Scandinavica 2005 84, 1-8. (IF: 1.327). Dodd JM, Flenady VJ, Cincotta R, Crowther CA.Progesterone for the prevention of preterm birth: a systematic review. Obstet Gynecol. 2008 Jul;112(1):127-34. |
| Copyright ©
2009
The University of Adelaide Last Modified 24/11/2009 ARCH CRICOS Provider Number 00123M |